AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
-1.45%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$635M
AUM Growth
+$635M
Cap. Flow
+$13M
Cap. Flow %
2.04%
Top 10 Hldgs %
39.19%
Holding
115
New
23
Increased
29
Reduced
18
Closed
15

Top Buys

1
ALKS icon
Alkermes
ALKS
$13.9M
2
CLYM
Climb Bio, Inc. Common Stock
CLYM
$11.9M
3
APGE icon
Apogee Therapeutics
APGE
$9.61M
4
ACLX icon
Arcellx
ACLX
$8.83M
5
INSM icon
Insmed
INSM
$8.38M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$9.7M
2
ABSI icon
Absci
ABSI
$5.82M
3
CYTK icon
Cytokinetics
CYTK
$5.61M
4
FULC icon
Fulcrum Therapeutics
FULC
$5.2M
5
AXSM icon
Axsome Therapeutics
AXSM
$4.81M

Sector Composition

1 Healthcare 89.38%
2 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ORKA
76
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$278K 0.03%
+72,484
New +$278K
RAPT icon
77
RAPT Therapeutics
RAPT
$187M
$229K 0.03%
+75,000
New +$229K
PASG icon
78
Passage Bio
PASG
$22.7M
$210K 0.02%
264,266
– –
GNLX icon
79
Genelux
GNLX
$125M
$195K 0.02%
+100,000
New +$195K
RCKTW icon
80
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.17M
$4.52K ﹤0.01%
75,000
– –
IOVA icon
81
Iovance Biotherapeutics
IOVA
$800M
$802 ﹤0.01%
+100
New +$802
SAVAW
82
DELISTED
Cassava Sciences, Inc. Warrant
SAVAW
– –
-24,200
Closed -$97.5K
GRTS
83
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
0
– –
ABSI icon
84
Absci
ABSI
$356M
– –
-1,025,000
Closed -$5.82M
AKRO icon
85
Akero Therapeutics
AKRO
$3.65B
– –
0
– –
ALNY icon
86
Alnylam Pharmaceuticals
ALNY
$58.6B
– –
0
– –
ALXO icon
87
ALX Oncology
ALXO
$54.6M
– –
0
– –
ANVS icon
88
Annovis Bio
ANVS
$44.4M
– –
0
– –
APLS icon
89
Apellis Pharmaceuticals
APLS
$3.51B
– –
-165,000
Closed -$9.7M
BSX icon
90
Boston Scientific
BSX
$159B
– –
-25,000
Closed -$1.71M
CRSP icon
91
CRISPR Therapeutics
CRSP
$4.82B
– –
0
– –
CYTK icon
92
Cytokinetics
CYTK
$5.98B
– –
-80,000
Closed -$5.61M
FULC icon
93
Fulcrum Therapeutics
FULC
$353M
– –
-550,339
Closed -$5.2M
GH icon
94
Guardant Health
GH
$8.11B
– –
0
– –
CBIO
95
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
– –
0
– –
IBRX icon
96
ImmunityBio
IBRX
$2.24B
– –
0
– –
IRWD icon
97
Ironwood Pharmaceuticals
IRWD
$201M
– –
0
– –
KRYS icon
98
Krystal Biotech
KRYS
$4.35B
– –
-26,746
Closed -$4.76M
MLTX icon
99
MoonLake Immunotherapeutics
MLTX
$3.78B
– –
-75,000
Closed -$3.77M
MRNA icon
100
Moderna
MRNA
$9.36B
– –
0
– –
1 2 3
4
5